1-9 of 9
Shruti Chaturvedi
Close
Sort by
Journal Articles

A descriptive analysis of fatal outcomes in immune thrombotic thrombocytopenic purpura in the USTMA TTP Registry

Mouhamed Yazan Abou-Ismail, Chong Zhang, Angela P. Presson, Shruti Chaturvedi, Ana G. Antun, Andrew M. Farland, Ryan Woods, Ara Metjian, Yara A. Park, Gustaaf de Ridder, Briana Gibson, Raj S. Kasthuri, Darla K. Liles, Frank Akwaa, Todd Clover, Lisa Baumann Kreuziger, Meera Sridharan, Ronald S. Go, Keith R. McCrae, Harsh Vardhan Upreti, Radhika Gangaraju, Nicole K. Kocher, X. Long Zheng, Jay S. Raval, Camila Masias, Spero R. Cataland, Andrew D. Johnson, Elizabeth Davis, Michael D. Evans, Marshall Mazepa, Ming Y. Lim
Journal: Blood Advances
Blood Adv (2024) 8 (3): 620–623.
https://doi.org/10.1182/bloodadvances.2023010807
Published: 2024
Includes: Supplemental data
Journal Articles

Evaluating complement dysregulation in livedoid vasculopathy using a functional assay

Harish Eswaran, Shruti Chaturvedi, Robert A. Brodsky, Gloria F. Gerber, Xiang-Zuo Pan, Stephan Moll
Journal: Blood Advances
Blood Adv (2023) 7 (21): 6604–6607.
https://doi.org/10.1182/bloodadvances.2022009142
Published: 2023
Journal Articles

C5 inhibition allows continued antineoplastic therapy in cancer- and chemotherapy-associated thrombotic microangiopathy

Clinical Trials & Observations
Hridaya Shah, Hang Chen, Xiang-Zuo Pan, Ara Metjian, Robert A. Brodsky, Evan M. Braunstein, Shruti Chaturvedi
Journal: Blood Advances
Blood Adv (2022) 6 (23): 6071–6074.
https://doi.org/10.1182/bloodadvances.2022008395
Published: 2022
Includes: Supplemental data
Journal Articles

Development and performance of a hereditary hemorrhagic telangiectasia-specific quality-of-life instrument

Clinical Trials & Observations
Raj S. Kasthuri, Shruti Chaturvedi, Sonia Thomas, Nathan Vandergrift, Carla Bann, Nicole Schaefer, Marianne S. Clancy, Reed Pyeritz, Keith R. McCrae
Journal: Blood Advances
Blood Adv (2022) 6 (14): 4301–4309.
https://doi.org/10.1182/bloodadvances.2022007748
Published: 2022
Includes: Supplemental data
Journal Articles

Eculizumab for refractory thrombosis in antiphospholipid syndrome

Habiba Hussain, Michael D. Tarantino, Shruti Chaturvedi, Keith R. McCrae, Jonathan C. Roberts
Journal: Blood Advances
Blood Adv (2022) 6 (4): 1271–1277.
https://doi.org/10.1182/bloodadvances.2021005657
Published: 2022
Journal Articles

Cardiovascular disease is a leading cause of mortality among TTP survivors in clinical remission

Clinical Trials & Observations
Senthil Sukumar, Max Brodsky, Sarah Hussain, Lisa Yanek, Alison Moliterno, Robert Brodsky, Spero R. Cataland, Shruti Chaturvedi
Journal: Blood Advances
Blood Adv (2022) 6 (4): 1264–1270.
https://doi.org/10.1182/bloodadvances.2020004169
Published: 2022
Includes: Supplemental data
Journal Articles

Continuous-infusion von Willebrand factor concentrate is effective for the management of acquired von Willebrand disease

Clinical Trials & Observations
Kathryn E. Dane, John P. Lindsley, Thomas Kickler, Michael B. Streiff, Alison Moliterno, Jennifer Yui, Rakhi Naik, Shruti Chaturvedi
Journal: Blood Advances
Blood Adv (2021) 5 (14): 2813–2816.
https://doi.org/10.1182/bloodadvances.2021004843
Published: 2021
Journal Articles

Outcomes of a clinician-directed protocol for discontinuation of complement inhibition therapy in atypical hemolytic uremic syndrome

Clinical Trials & Observations
Shruti Chaturvedi, Noor Dhaliwal, Sarah Hussain, Kathryn Dane, Harshvardhan Upreti, Evan M. Braunstein, Xuan Yuan, C. John Sperati, Alison R. Moliterno, Robert A. Brodsky
Journal: Blood Advances
Blood Adv (2021) 5 (5): 1504–1512.
https://doi.org/10.1182/bloodadvances.2020003175
Published: 2021
Journal Articles

Sex determines the presentation and outcomes in MPN and is related to sex-specific differences in the mutational burden

Clinical Trials & Observations
Theodoros Karantanos, Shruti Chaturvedi, Evan M. Braunstein, Jerry Spivak, Linda Resar, Styliani Karanika, Donna M. Williams, Ophelia Rogers, Christopher D. Gocke, Alison R. Moliterno
Journal: Blood Advances
Blood Adv (2020) 4 (12): 2567–2576.
https://doi.org/10.1182/bloodadvances.2019001407
Published: 2020
Includes: Supplemental data